News Release

Participation and support of "Study: Osaka Kansai International Arts Festival"

Rohto Pharmaceutical's "BÉLAIR LAB" x Orix Buffaloes: Supporting the high performance of players with fragrance

Rohto Children's Dream Fund has selected 8 organizations as recipients for its second round of grants.

New possibilities for anti-anxiety research using unused resources from Mie Prefecture (Niihime pomace and olive leaves)

We have formed a capital and business alliance with Futsupa Co., Ltd., which promotes industrial DX utilizing AI and image analysis technology.

Selected as a "Certified Health & Productivity Management Outstanding Organization" for the second time, and certified as a "Certified Health & Productivity Management Outstanding Organization (White 500)" for the eighth time in five consecutive years.

Antibacterial properties of lactic acid fermented hyaluronic acid discovered

Rohto Pharmaceutical has released its "Fertility Treatment White Paper 2024," showing signs of an increase in "fertility treatment men" who are proactively involved in fertility treatment.

Formulated with ingredients to reduce eye strain! Introducing "DyDo x Rohto Berry Water," a new product developed in collaboration with DyDo Drinko.

For growing children who want to do their best in physical development, studying, and sports. A chewable type is now available from the growth-support brand "Senobic".